
Micron Technology
Vertically integrated IDM: designs and fabs its own DRAM and NAND in owned fabs (US, Japan, Taiwan, Singapore), sells to OEMs/hyperscalers/distributors. Deeply cyclical commodity historically, now partly de-commoditized via take-or-pay HBM/Strategic Customer Agreements (fact: take-or-pay strategic customer agreements carried ~$134B of remaining performance obligations at Sep 3 2026, 10-K).
Sources — 3 figures with citations
- management, 2026-11-05filed2026-11-05Director Linnie M. Haynesworth (on the board since Feb 2021; Audit and Compensation committees; chaired the Security Committee 2024-2026) will retire at the fiscal 2026 annual shareholders meeting expected on Jan 14, 2027, leaving an eight-member board; the remaining eight directors, including chairman and CEO Sanjay Mehrotra, were nominated for re-election (8-K Item 5.02; notice given Nov 2, 2026).investors.micron.com — CONFIRMED; recorded Nov 12 2026; source dated 2026-11-05
- deal, 2026-11-10filed2026-11-10Anthropic's S-1/A No. 2, filed Nov 10, 2026 (EDGAR accession 0001628280-26-072484), set an IPO range of $70-$78 per share for 825 million shares (pricing Nov 18, Nasdaq ticker 'ANT' trading Nov 19; up to $1.405 trillion fully diluted at the top of the range) and, per CNBC, agreed to sell $26 billion of Class N common stock at the IPO price, not subject to lock-up, to Advanced Micro Devices, Broadcom, Google, Micron, Microsoft, Nvidia and Taiwan Semiconductor Manufacturing Co.; per-company amounts were not disclosed.cnbc.com — REPORTED; recorded Nov 12 2026; source dated 2026-11-10
- Watched signal: DRAM/NAND spot + contract ASP trendfiled2026-11-12Still rising, more slowly: TrendForce's Nov 4 update has mainstream DDR4 1Gx8 3200MT/s spot down 0.09% week-on-week to US$46.82 (Nov 3) with buyers sidelined by the spot premium, 512Gb TLC NAND wafer spot down 4.33% to US$16.152, and server DRAM contract prices still rising; its Oct 30 research has 4Q26 PC DRAM contract prices rising at a slower pace with many November contracts settling at slight increases no month-on-month contract decline, so the two-consecutive-month falsifier stays unmet.trendforce.com — Outcome of a signal this entry said to watch; recorded Nov 12 2026.
The thesis on this name
State of AI Compute
Only US-listed integrated DRAM+NAND pure-play at ~10x forward with record 85% GM and $100B+ committed backlog — cheap ONLY if the super-cycle outruns a normal one; the 'buy the dip' entry rests on a mis-dated, mis-attributed selloff (the larger June-4/5 leg was a Broadcom AI-demand miss, not cycle fear), so gate entry on realized prints + a demand-leg monitor, not a price flush.
State of AI Compute
Long Micron over 9-15 months: at ~$1,232 (7.4x fwd EPS on a $31±1 Q4 FY26 guide and a $100B contracted backlog) the market is pricing a normal cyclical roll-over, but a structurally supply-constrained, contract-locked AI-memory cycle (HBM sold out through 2027, memory rising from ~30% to ~48% of hyperscaler capex) keeps realized prints above through-cycle for longer than consensus de-rate models assume — edge is analytical (correctly weighting contract-backed durability vs. the reflexive low-multiple-on-peak-earnings discount).
State of the Memory Supercycle
The only US-listed pure-play memory maker and the cleanest expression of the cycle. FQ3'26 printed ~81% gross margin (vs 27% a year earlier), HBM4 revenue already >$1B, and the entire 2026 HBM book is sold out under multi-year contracts with ~$22B of hyperscaler cash deposits prepaid (Micron FQ3'26 prepared remarks, Jun 2026). FQ4 guide is ~$50B revenue and ~86% gross margin. Critically the bull case is no longer HBM-only: TrendForce flags DDR5 contract profitability surpassing HBM3e in 2026 (Oct 2025), and Micron's 3:1 HBM-to-DDR5 wafer conversion means every HBM ramp tightens the far-larger commodity DRAM pool Micron also sells. Through-cycle this is the lowest-cost-curve US name with the strongest free-cash inflection; own it for the roll, sized to a cycle-aware entry not the FQ4-margin peak.
State of the Memory Supercycle
Distinct from the core MU compounder call: the mispricing is timing, not the franchise. The Street treats MU as a peak-margin cyclical to be sold at ~86% GM, but the through-cycle FCF profile has structurally improved (HBM long-term contracts + prepayments smooth the trough) — TradingView/GuruFocus note 'the memory cycle has changed' on cash flow. The asymmetric trade is to add on cycle-fear pullbacks (a CXMT-glut headline, a single soft DDR5 print) rather than chase the margin peak. Size the rent for the roll: the entry band, not the franchise, is what's undervalued here.
State of the Memory Supercycle
Avoid CHASING memory makers into the FQ4'26 ~86%-gross-margin peak. The weighted cycle peak clusters around Q1'27 (range H2'26–H2'27) and TechInsights forecasts a 2027 semiconductor/memory downturn; no prior memory upcycle has lasted beyond ~30 months and this one is already at that threshold (useLuminix / blocksandfiles, 2026). Historically the moment DRAM feels safest — sold-out capacity, record prices, rising targets — is closest to the top. This is an avoid-the-entry call on the same MU we own: the franchise is fine, but paying peak-margin multiples at month-30 of an unprecedented upcycle, into a live CXMT glut falsifier, is the canonical way to lose money in memory. Buy the dislocation, do not chase the print.
State of the Memory Supercycle
Own the only US-listed pure memory maker through the cycle — HBM sold out 2026, record 84.6% GM, but buy the inevitable cyclical pullbacks, don't chase the post-print +16% spike.
State of the Memory Supercycle
The single best US expression of HBM + DRAM; sold-out 2026 HBM, record margins. Accumulate on >15% pullbacks — entry is late-cycle at an all-time high.
Earnings, margins, COGS & capex
Micron is in the steepest up-cycle in its history: revenue went $13.6B → $23.9B → $41.5B → $54.2B across Q1–Q4 FY26 (fact), non-GAAP gross margin 56.8% → 74% → 84.9% → 87.0% (fact), and Q1 FY27 is guided to $61.5B ± $1.5B of revenue at ~86.25% non-GAAP gross margin and ~$38.15 non-GAAP EPS (fact). The swing is driven by AI data-center DRAM, sold-out HBM, and a pricing spike, with take-or-pay strategic customer agreements carrying ~$134B of remaining performance obligations (fact, 10-K). The key debate is not whether numbers are great today but how much of the ~86% margin and the price spike is peak-cyclical vs structurally durable — the Q1 FY27 guide of ~86.25% gross margin sits slightly below Q4's 87.0%, and its revenue midpoint is about +13% above Q4 after +31% in Q4 (computed).
Income statement — where each revenue dollar goes
% of revenueOf every $1 of revenue, ~13¢ is cost of goods and ~5¢ operating expense, leaving ~82¢ of operating profit (~70¢ net).
Revenue trend
Margins
up (56.8%→74%→84.9%→87.0%)
up (+1.1pts QoQ to 82.3%; non-GAAP opex $2.57B vs $1.52B in Q3)
up
up (operating CF $43.97B vs $25.39B in Q3)
COGS structure
COGS is dominated by silicon-wafer fab cost: depreciation of multi-billion-dollar fabs (the single largest fixed cost — every node/capacity build adds D&A), raw silicon wafers, ultra-pure chemicals/gases, photomasks, and high power/water for fab operations, plus advanced packaging/test for HBM (TSV stacking is yield-limiting and cost-heavy). In a memory up-cycle, price runs far ahead of largely-fixed COGS, which is why gross margin explodes from 57% to 86%; in a down-cycle the same fixed D&A crushes margin negative. HBM carries 3-4x the silicon content of standard DRAM per bit (est.), so HBM mix is cost-dilutive on bits but margin-accretive on revenue.
Capex
FY26 net capex of $27.37B net of government incentives (fact, 10-K), $10.77B of it in Q4 alone, and ~$11.5B in Q1 FY27 and ~$25B in the first half of FY27 with the second half higher (fact, 10-K) — funding HBM/advanced-DRAM capacity (1-gamma/EUV nodes), HBM4/HBM4E TSV packaging, and US greenfield fabs (Idaho, New York) backed by CHIPS Act incentives. This is the highest capex in company history and the central bear risk: it adds future D&A and supply that could re-commoditize the market when AI demand normalizes.
Latest earnings
Beat against guidance: revenue $54.23B vs $50.0B ± $1.0B guided; non-GAAP EPS $33.42 vs $31.00 ± $1.00 guided; non-GAAP gross margin 87.0% vs ~86% guided (fact).
Q1 FY27 (fact, issued Sep 30 2026): revenue $61.5B ± $1.5B; non-GAAP gross margin ~86.25% (~85.95% GAAP); non-GAAP opex ~$2.06B (~$2.31B GAAP); diluted EPS $38.15 ± $1.00 non-GAAP ($37.84 ± $1.00 GAAP). Net capex (10-K): FY26 was $27.37B; for FY27 ~$11.5B in Q1 and ~$25B in the first half, higher in the second half. The Q4 guide of $50.0B ± $1.0B was exceeded by the $54.23B actual (fact).
- DRAM revenue (FY26)
- $100.68B, ~76% of revenue (computed), against $28.58B in FY25 (fact, 10-K); Q3 FY26 was $31.3B, +343% YoY and +67% QoQ (fact)
- NAND revenue (FY26)
- $31.79B, ~24% of revenue (computed), against $8.50B in FY25 (fact, 10-K); Q3 FY26 was $9.9B, ~+361% YoY, nearly doubled QoQ on mid-single-digit % bit growth (fact)
- Data-center revenue (Q4 FY26)
- $34.29B in the quarter (computed: Cloud Memory $16.28B plus Core Data Center $18.00B), 63% of revenue and +36% on $25.29B in Q3, a ~$137B annualized run rate (computed); in Q3 data-center SSD revenue was >$5B, more than doubled sequentially (fact, Q3 FY26 call)
- Contracted backlog (SCAs)
- ~$134B of remaining performance obligations on take-or-pay strategic customer agreements at Sep 3 2026, with $12.75B of customer cash deposits received in FY26 and $7B of customer letters of credit (fact, 10-K). At the Q3 FY26 call (Jun 24 2026) the company cited 16 agreements with ~$100B of minimum contracted revenue, covering ~20% of DRAM volume and up to one third of NAND volume, and $22B+ in total cash and financial commitments including ~$18B of upfront deposits (fact, call — a slide summary instead reported '$22B in upfront customer cash'; the transcript figure is used here); the 10-K does not reproduce those measures, and the number of agreements and the volume covered after fiscal Q4 were not found in a primary source. Management targets ~half of company revenue under SCAs over time.
- Cash generation & balance sheet (Q4 FY26)
- Operating cash flow $43.97B in Q4 FY26 and $89.68B for FY26; adjusted FCF $33.20B in Q4 (~61% of revenue) and $62.31B for FY26; Q4 net capex $10.77B (fact). Cash, marketable investments and restricted cash $73.48B vs $5.18B total debt ($0.49B current, $4.69B long-term) at Sep 3 2026 (fact, 10-K).
- Capital returns
- Buybacks paused in fiscal Q3 and Q4 ($650M for FY26 in total: $300M in Q1 and $350M in Q2); quarterly dividend raised 30% to $0.15/share, with a stated intent to return 100% of excess cash over time, primarily via buybacks (fact; the raise appears to date from the Q2 FY26 report — exact announcement date not verified).
- Remaining performance obligations (strategic customer agreements)
- ~$134B at Sep 3 2026, of which $13B is recognized as customer-deposit contract liabilities; about one-fourth expected to be recognized as revenue within 12 months. Cash deposits of $12.75B received in FY26, nearly all scheduled to be repaid between 2029 and 2031 (fact, 10-K)
Growth drivers
- HBM (high-bandwidth memory) for AI accelerators — sold out through CY2026, booked into 2027, HBM4 revenue already >$1B and ramping 2x faster than HBM3E (fact, Q3 FY26)
- Data-center DRAM + high-cap server DIMMs — data-center revenue was $34.29B in Q4 FY26 (computed: Cloud Memory $16.28B plus Core Data Center $18.00B), 63% of revenue and the majority of the business
- Severe DRAM/NAND pricing — tight industry supply (Micron can fill only half-to-two-thirds of HBM demand) driving ASPs up across the board
- Data-center SSD / enterprise NAND — Q3 data-center SSD revenue more than doubled QoQ (fact); NAND revenue +361% YoY
- Strategic Customer Agreements — take-or-pay contracts (~$134B of remaining performance obligations at Sep 3 2026, 10-K) converting commodity sales into contracted, margin-floored revenue
- HBM4E custom base-die with TSMC (2027) — moves Micron up the value chain into customized, stickier AI memory
Reported financials — SEC EDGAR
Audited GAAP figures pulled from SEC filings · latest filing 2026-10-09. The audited primary-source spine — not financial advice.
Revenue — annual (GAAP)
Margins & balance sheet — FY’26
Bull & bear
At $855.10 (fact, Nov 3 2026 close) and a ~$967.5B market cap (computed) — ~32% below the 52-week high — the market pays ~5.6x the annualized Q1 FY27 guide midpoint ($38.15 non-GAAP EPS x 4 = $152.60, computed) and ~11.3x FY26 non-GAAP EPS of $75.52 (computed) for a business whose reported economics did not break. Q4 FY26 non-GAAP gross margin was 87.0% (86.8% GAAP) (fact), running ~4.7pt above the 82.3% non-GAAP operating margin. HBM4 is in high-volume production for NVIDIA Vera Rubin, CY2026 HBM supply is sold out with pricing and volume locked, and the strategic customer agreements carry ~$134B of remaining performance obligations, backed by $12.75B of customer cash deposits received in FY26 (fact, 10-K) — the strongest de-risking fact in the case.
- The July de-rate was multiple compression, not an earnings event: MU fell ~28.7% in July (from a $1,154.29 Jun 30 close to $823.03, fact; -29.4% from the ~$1,166 Jun 25 close) inside a sector-wide move — the SOX closed Jul 31 2026 at 11,311.08, -22.7% from its Jun 22 2026 record close of 14,634.72 (fact, Nasdaq official index page) — while Q3 DRAM contracts were reported settling 20-30% HIGHER through the selloff and the Q4 print then beat that guide: $54.23B revenue against $50.0B ±$1.0B guided, an 87.0% non-GAAP gross margin against ~86% and $33.42 non-GAAP EPS against $31.00 ±$1.00 (fact, Sep 30 2026); the stock closed Nov 3 2026 at $855.10, +3.9% from the Jul 31 close and ~32% below the 52-week high (computed)
- Gross margin is the metric this thesis argues about, and it kept rising: 87.0% non-GAAP gross margin (86.8% GAAP) on $54.23B revenue in Q4 FY26 (fact) — a company record, up from 84.9% (84.6% GAAP) on $41.46B in Q3 — with 82.3% non-GAAP operating margin (80.7% GAAP), non-GAAP net income of $38.40B (GAAP $37.70B), $43.97B of operating cash flow and $33.20B of adjusted FCF (~61% of revenue, fact)
- The contracted book is large and appears in the 10-K: take-or-pay strategic customer agreements carry ~$134B of remaining performance obligations at Sep 3 2026, about one-fourth of it to be recognized within twelve months and all of it within five years, backed by $12.75B of customer cash deposits received in FY26 and $7B of customer letters of credit (fact, 10-K). At the Q3 FY26 call management cited 16 agreements covering ~20% of DRAM and up to one third of NAND volume (fact; coverage after fiscal Q4 was not found in a primary source) and targets ~half of company revenue under these agreements over time. Cash in hand ahead of shipment is a materially harder floor than a signed minimum, though the 10-K notes the obligations rest on committed volumes at minimum pricing and are not indicative of future revenue under the contracts
- The HBM qualification risk we were watching has cleared: high-volume production of HBM4 (36GB 12-high) designed for NVIDIA Vera Rubin at >11 Gb/s pin speed and >2.8 TB/s bandwidth (~2.3x HBM3E) with >20% better power efficiency, and 16-high 48GB samples shipped to customers (fact, Jul 2026); calendar-2026 HBM supply is fully sold out with pricing and volume locked, HBM4 included. Data-center revenue was $34.29B in Q4 FY26 (computed: Cloud Memory plus Core Data Center business units, ~$137B annualized), up 36% on Q3, and data-center SSD revenue was >$5B in Q3, more than doubled sequentially (fact)
- The balance sheet absorbs the capex step-up without dilution and on a long timeline: ~$68.3B net cash at end Q4 FY26 ($73.48B cash, marketable and restricted investments vs $5.18B total debt, with $10.0B of debt repaid in FY26) against $33.20B of Q4 adjusted FCF and $12.75B of customer deposits received in FY26 (fact, 10-K). More than half of the FY27 build is construction — first wafers mid-2027 at Boise, the second fab late-2028 (fact, Jul 9 2026) — so it is a self-funded multi-year commitment, not a leveraged race to add near-term bits
The bear case rests on two things that verify. First, essentially all of the sequential growth in Q3 was price: DRAM bit shipments rose only low-single-digit % QoQ while DRAM ASPs rose low-60s % QoQ (fact, Q3 FY26 call; the Q4 split was not verified), and the same fixed fab D&A that produces an 87.0% gross margin produces a negative one when price reverts. Second — and this is where a high conviction is genuinely exposed — the 'structural, contract-locked' claim rested at the Q3 FY26 call on floor prices covering only ~20% of DRAM volume (fact; coverage after fiscal Q4 was not found in a primary source), so roughly four fifths of DRAM volume priced outside that mechanism, and the mechanism has never been run through a memory down-cycle. The FY27 capex step-up to ~$25B in the first half versus $27.37B in all of FY26 (fact, 10-K) and a now-listed, funded CXMT (fact, Jul 27 2026) are real additions to the bear case, but both land with a lag and on the conventional-DRAM tail the thesis already discounted. The 'meaningful moderation in the rate of price increases' quotation is not used: it cannot be found in the Q3 press release or in a transcript pass, and on that call management pointed instead to supply tightness persisting well beyond 2027 while guiding gross margin up. Q4 then beat its ~86% gross-margin guide at 87.0%, while the Q1 FY27 gross-margin guide of ~86.25% is slightly lower and the revenue guide implies about +13% sequential growth after +31% in Q4 (computed).
- Growth is price, not bits: DRAM bit shipments +low-single-digit % QoQ against DRAM ASPs +low-60s % QoQ (fact, Q3 FY26 call). The Q3 revenue line (+345% YoY / +74% QoQ), built almost entirely on price, is not a steady-state growth rate, and Q4 (+379% YoY / +31% QoQ) came without a verified bit-versus-price split; this is the load-bearing number for the mean-reversion debate
- Coverage, not capex, is the actual structural vulnerability: at the Q3 FY26 call the SCAs floored ~20% of DRAM volume and up to one third of NAND volume (fact; the 10-K gives no volume share), which left ~80% of DRAM volume pricing outside the floor mechanism, and take-or-pay floor pricing has never been tested through a down-cycle. If the 'structural' half of this thesis fails, it fails here — not on a competitor's IPO and not on our own file errors
- The FY27 capex step-up, restated to what it supports: guided at ~$11.5B for Q1 and ~$25B for the first half of FY27, with the second half higher, vs $27.37B in all of FY26 (fact, 10-K), plus >$250B of planned US investment through 2035, first concrete at Clay NY more than a quarter early, two Boise fabs under construction (first wafers mid-2027, second late-2028) (fact, Jul 9 2026). More than half is construction, so it is neither near-term bit supply nor near-term D&A, and it is self-funded against $33.20B of Q4 adjusted FCF and ~$68.3B net cash. The tell is not the capex number but whether contracted coverage expands alongside it — uncontracted capacity is the glut mechanism; contracted capacity is not
- China supply is now a named, funded entity — with the mechanism stated correctly: CXMT listed on the Shanghai A-share market Jul 27 2026, raising RMB 57.92B (~$8.55-8.6B) at RMB 8.66/share, the largest mainland-China semiconductor IPO on record, closing up ~466% on debut; it is on track to exit 2026 at ~350,000 WSPM, within ~25,000 WSPM of Micron's own capacity, at ~7.6% global DRAM share, up from ~4.7% a quarter earlier (fact). The IPO is a capital-markets event — the ~350,000 WSPM plan pre-dates it — and >98% of CXMT revenue is COMMODITY DRAM with effectively no HBM presence (fact). That is confirmation of a risk this thesis already carried, on the segment it already discounted, not falsification of it
- The competitive-position leg of the bear case is currently UNQUANTIFIED, not disproven: the '#3 in HBM at ~20% share, ~20% of NVIDIA's HBM4/Rubin allocation vs SK Hynix's ~two-thirds' figure has no primary source and is not used. Verified share is OVERALL DRAM — Samsung ~39%, SK Hynix ~29%, Micron ~22% (fact) — which is not an HBM figure. The honest statement is that we do not know Micron's HBM share, and that gap sits on the bear side of the ledger
- Capital returns were pulled in while FCF peaked: buybacks were PAUSED in fiscal Q3 and Q4 (after $300M in Q1 and $350M in Q2 FY26) against $18.30B of adjusted FCF in Q3 and $33.20B in Q4, with the quarterly dividend raised 30% to $0.15/share — immaterial against that cash generation (fact). Cash is being routed to a fixed-cost base that is being enlarged for a decade at the point in the cycle when current-quarter economics are at a record
What it is worth
Forward earnings / through-cycle normalization (P/E on an annualized run-rate, sanity-checked against mid-cycle EPS), because the debate is still peak-vs-normalized earnings, not asset value. Each case is FY2027 consensus EPS ($176.50, fiscal year to Aug 2027; estimate, aggregator, Oct 29 2026) times a named multiple: bull is the multiple the average analyst target implies, base is today's multiple (up to the named-peer median), bear is the cheapest named peer. Peer multiples are Nov 3 2026 closes over calendar-2027 consensus EPS for SK hynix and Samsung and over the average of the fiscal years to Jun 2027 and Jun 2028 for SanDisk, estimates from an aggregator; the anchor is the Nov 3 2026 close. All figures est. except cited inputs.
~$466 (-45.5% from the close)
SK hynix's 2.64x, the cheapest named peer and, like Micron, a DRAM and HBM maker, on FY27 consensus EPS of $176.50 (estimates, aggregator; SK hynix on calendar-2027 EPS, Micron's fiscal year ends Aug 2027). Consensus is held and the multiple carries the downturn. Samsung (~2.90x) would give ~$512 and SanDisk (~4.37x) ~$772 (computed). Driver: cyclical roll-over — Micron's own FY27 step-up to ~$25B of net capex in the first half alone, with the second half higher, plus a funded CXMT at ~350,000 WSPM re-commoditize conventional DRAM and margins mean-revert against a permanently larger fixed-cost base; the SCAs floored revenue on ~20% of DRAM volume at the Q3 FY26 call but not the ~86%-guide spot economics on the rest, and that uncovered ~80% is what this case really prices. The June bear of ~$600-750 cut earnings (an assumed ~8-10x on FY26 non-GAAP EPS of $75.52) and equals 3.4-4.25x today's FY27 consensus: it sits above this bear because the Korean makers trade lower than Micron today (computed). The bear is 2.4x the 52-week low of $192.59.
~$855 (0.0% from the close)
today's multiple, 4.84x FY27 consensus EPS of $176.50 (estimate, aggregator). Driver: super-cycle real but moderating, with contracted visibility priced against eventual normalization. The named peers trade lower (SK hynix ~2.64x, Samsung ~2.90x, SanDisk ~4.37x on calendar-2027 EPS, computed), so their median is below today's multiple and there is no step up. The June base of ~$1,200-1,300 did not hold: it was 9.7-10.5x the $124 run-rate quoted then, and the price is now 27% below the ~$1,166 Jun 25 close (computed); on consensus FY27 EPS of $176.50 that range would need 6.8-7.4x.
~$1,562 (+82.7% from the $855.10 close): the multiple the average analyst target implies, 8.85x FY27 consensus EPS of $176.50 (target $1,562 across 49 analysts; estimates, aggregator). Structural-cycle case: the contracted book (~$134B of remaining performance obligations, $12.75B of customer deposits received in FY26) holds, HBM stays sold out beyond CY2026, FY27 EPS holds at or above the ~$153 annualized Q1 FY27 guide run-rate ($38.15 x 4, computed), and the market pays a structural multiple on contracted earnings. The June bull of ~$1,600+ did not hold: it was 12.9x the $124 annualized run-rate quoted then and would be 9.1x today's FY27 estimate (computed); the 52-week high of $1,255.00 is 7.1x.
At $855.10 (fact, Nov 3 2026 close) and a ~$967.5B market cap (computed), the stock is ~32% below its 52-week high and +3.9% from the Jul 31 2026 close of $823.03 (computed). Three items the read turns on: (1) Q4 FY26 gross margin is 87.0% non-GAAP / 86.8% GAAP, ~4.7pt above the 82.3% non-GAAP operating margin — the metric this thesis is about; (2) no bearish ASP signal rests on the 'meaningful moderation in the rate of price increases' quotation, which could not be found in the Q3 press release or a transcript pass; (3) Micron's HBM share is not known, and the '#3 in HBM at ~20% share vs SK Hynix ~two-thirds' figure has no primary source, so it is not used. At $855.10 the stock is ~5.6x the annualized Q1 FY27 guide midpoint ($38.15 x 4 = $152.60) and ~11.3x FY26 non-GAAP EPS of $75.52 (computed); on FY27 consensus non-GAAP EPS of $176.50 it is ~4.8x (estimate, aggregator, Oct 29 2026). Named peers on calendar-2027 consensus EPS at the same close: SK hynix ~2.64x, Samsung ~2.90x and SanDisk ~4.37x (average of its fiscal years to Jun 2027 and Jun 2028); median ~2.90x (computed; estimates, aggregator). Micron trades above all three. The cases are FY27 consensus EPS times the average-target multiple (bull, 8.85x), today's multiple (base, 4.84x) and the cheapest named peer's multiple (bear, 2.64x). The June cases (bull ~$1,600+, base ~$1,200-1,300, bear ~$600-750) did not hold: they were set against the ~$1,166 Jun 25 close and a $124 annualized run-rate, and the Nov 3 close is 27% lower (computed) on FY27 consensus EPS of $176.50 (estimate, aggregator). The FY27 capex step-up (~$25B of net capex in the first half alone, fact, 10-K) raises the fixed-cost base the bear case discounts, but on a mid-2027 / late-2028 wafer timeline, self-funded, and matched against ~$134B of remaining performance obligations. The Q4 FY26 print adjudicated part of what the cases turn on: revenue of $54.23B and an 87.0% non-GAAP gross margin beat the $50.0B ±$1.0B and ~86% guide. What it leaves open is the Q1 FY27 guide ($61.5B ±$1.5B at ~86.25% gross margin, about +13% sequential growth after +31% in Q4, computed) and how contracted coverage behaves in a down-cycle, which no print has tested.
SWOT
Strengths
- Only US-headquartered integrated DRAM+NAND IDM — strategic/geopolitical premium, CHIPS Act incentives, and a >$250B US investment commitment through 2035 with a 40%-of-DRAM-in-the-US target (fact, Jul 9 2026)
- Record reported economics — $54.23B revenue, 87.0% non-GAAP gross margin (86.8% GAAP), 82.3% non-GAAP operating margin (80.7% GAAP), $38.40B non-GAAP net income (GAAP $37.70B), $43.97B operating cash flow and $33.20B adjusted FCF in Q4 FY26 (fact)
- Take-or-pay strategic customer agreements carrying ~$134B of remaining performance obligations, with $12.75B of customer cash deposits received in FY26 and $7B of customer letters of credit (fact, 10-K); at the Q3 FY26 call management cited 16 agreements and targeted ~half of company revenue under them over time
- Record balance sheet — ~$68.3B net cash ($73.48B cash, marketable and restricted investments vs $5.18B total debt; $10.0B of debt repaid in FY26, fact) against a history of leverage — funds the FY27 build without dilution
- HBM4 in high-volume production for NVIDIA Vera Rubin (36GB 12-high, >11 Gb/s, >2.8 TB/s, >20% better power efficiency; 16-high 48GB samples shipped) with CY2026 HBM supply sold out and pricing/volume locked (fact, Jul 2026)
Weaknesses
- Structurally a commodity cyclical — the sequential growth is essentially all price — DRAM bits +low-single-digit % QoQ vs ASPs +low-60s % QoQ (fact, Q3 FY26 call) — so earnings power is regime-dependent, not steady
- Contract coverage is thin where it matters and untested — SCA floor prices covered ~20% of DRAM volume and up to one third of NAND volume at the Q3 FY26 call (fact; later coverage not found in a primary source), leaving ~80% of DRAM volume outside the floor mechanism, which has never been run through a down-cycle
- Capital intensity is extreme and rising — ~20% of revenue in Q4 FY26 ($10.77B net capex, fact), $27.37B in FY26 net of incentives, and ~$25B planned for the first half of FY27 alone with the second half higher (fact, 10-K) — future D&A and future supply, on a mid-2027 / late-2028 wafer timeline rather than a near-term one
- Competitive position in DRAM is third — Samsung ~39%, SK Hynix ~29%, Micron ~22% (fact). Any HBM-specific share figure is UNVERIFIED and must not be published — the '~20% HBM share / ~20% of Rubin allocation' figure has no primary source and is not used, leaving the competitive leg unquantified
- Heavy customer concentration in a few hyperscalers and NVIDIA for HBM — de-qualification on one platform is material
- Capital returns are subordinated to the build — buybacks paused in fiscal Q3 and Q4 despite $18.30B and $33.20B of adjusted FCF in those quarters (fact); the dividend at $0.15/share (raised 30%) is immaterial against that cash generation
Opportunities
- AI memory cycle extends — if HBM/data-center demand stays supply-short, contracted margins persist far longer than a normal cycle — data-center revenue was $34.29B in Q4 FY26 (computed: Cloud Memory plus Core Data Center business units; ~$137B annualized) after exceeding $25B in Q3, with data-center SSD revenue >$5B and more than doubled sequentially in Q3 (fact)
- Convert cleared HBM4 qualification into share — HBM4 shipping in high volume for Vera Rubin and 16-high 48GB sampling (fact, Jul 2026); HBM4E custom base die with TSMC (2027) moves Micron up-stack into differentiated, stickier custom memory
- Grow SCA coverage beyond ~20% of DRAM volume toward management's ~half-of-revenue target (fact, Q3 FY26 call) — more take-or-pay plus more upfront cash is the cleanest available de-risking of the cycle, and the single item that would most strengthen the structural claim
- US onshoring as a commercial asset, not just a cost — >$250B through 2035, Clay NY first concrete a quarter early, two Boise fabs (first wafers mid-2027, second late-2028), and up to $3B committed to the US supply chain including $500M of strategic financing to GlobalWafers (fact, Jul 9 2026)
- Enterprise/data-center SSD and high-capacity DIMMs as a second AI-leveraged leg — NAND revenue $31.79B in FY26, ~24% of the total (computed) against $8.50B in FY25; DRAM revenue $100.68B, ~76% of the total, against $28.58B (fact, 10-K)
Threats
- CXMT is now a funded, near-Micron-scale DRAM entrant — ~$8.55-8.6B raised in the largest mainland-China semiconductor IPO on record (Jul 27 2026), ~350,000 WSPM exiting 2026 (within ~25,000 WSPM of Micron), ~7.6% global DRAM share up from ~4.7% a quarter earlier (fact) — concentrated in commodity DRAM (>98% of its revenue, effectively no HBM). The listing capitalized a plan that pre-dated it; the threat is to the conventional-DRAM base, not the AI-memory franchise
- Industry-wide capacity adds — Micron's own FY27 step-up to ~$25B of net capex in the first half alone, with the second half higher (fact, 10-K) alongside SK Hynix and Samsung expansion — are the textbook glut setup; the tell to watch is CY2027 supply-growth guidance against bit-demand growth, and specifically whether added capacity arrives contracted or uncontracted
- AI capex digestion — demand is hostage to hyperscaler and NVIDIA buildout. One early behavioural straw — reports that CoreWeave is exploring financial hedges against a decline in memory costs (Jul 2026) — is secondary-source only and UNCONFIRMED, and cannot carry weight until primary-sourced
- Permitting/delay risk on the US roadmap — a group of local residents filed suit against the ~$100B Clay, New York megafab campus (Jul 2026; filing date and case status NOT verified) — low near-term earnings impact, relevant to the long-dated supply picture
- Export-control / geopolitical whiplash affecting China revenue, equipment access, or customer routing — no new action was found on search, which is absence of evidence rather than confirmed absence
Moats, dependencies & bottlenecks
Moats
EUV 1-gamma, in-house HBM base die) real lead in cost/bit and HBM, but SK Hynix leads HBM and Samsung has deeper resources; parity is contested every node. Memory tech leadership is rented, not owned — it must be re-won each node with capex.
high capital barriers keep entrants out, but the three incumbents still compete on price into gluts, and China is funding entrants. The discipline is real this cycle (sold-out, contracted) but has broken in every prior cycle.
Contracted take-or-pay HBM/SCA backlog (~$134B of remaining performance obligations at Sep 3 2026) genuinely new for memory and floors revenue/margin, but covered only ~20% of DRAM volume at the Q3 FY26 call and is at floor prices, not spot. A cycle-dampener, not a permanent pricing moat; the bull case rests heavily on it holding.
Customer qualification / switching cost (HBM design-in to Nvidia/AMD accelerators) once qualified on a GPU platform, HBM is sticky for that generation, but re-qualified each generation and allocation is re-contested. Stickier than commodity DRAM; far less sticky than a logic foundry relationship.
durable as a geopolitical/scarcity asset and incentive stream, policy-dependent. Only Western integrated DRAM+NAND maker — a scarcity premium, not a cost moat.
Dependencies
HBM and data-center DRAM are the entire growth thesis; concentrated in a handful of AI buyers. A capex pause de-rates the stock fast.
Earnings power is regime-dependent; 86% gross margin assumes tight supply. The single largest risk factor.
Applied Materials, Lam, KLA, Tokyo Electron) EUV/etch/deposition tools gate node and HBM capacity; long lead times and export controls add risk.
Moving the HBM4E base die to TSMC adds a foundry dependency and shares value, but enables customization for AI accelerators.
Two-way: controls on equipment access and on China revenue/customer routing; geopolitical whiplash can hit supply and demand simultaneously.
Advantages
- Only US-listed integrated DRAM+NAND IDM — geopolitical/secure-supply premium plus CHIPS Act incentives no pure-play foreign rival captures
- Record net-cash balance sheet (~$68.3B) — self-funds record capex and survives the next down-cycle without dilution, a first for cyclical Micron
- Contracted, margin-floored backlog (~$134B of remaining performance obligations on take-or-pay agreements, 10-K) that dampens the historical boom-bust earnings volatility
- Both DRAM (incl. HBM) and NAND under one roof — captures the full AI-memory bill of materials (HBM + high-cap DIMMs + data-center SSD)
- Operating leverage proven this cycle — non-GAAP opex rose ~2.1x year on year ($1.21B to $2.57B) while revenue rose ~4.8x — incremental revenue dropped through at ~95% non-GAAP operating margin (computed: $40.68B more operating income on $42.91B more revenue)
- Competitive HBM4 (>11Gbps, in-house base die) and a TSMC HBM4E custom roadmap — a credible #2/#3 with a path up the value chain
Weaknesses
- Commodity-cyclical core — earnings swing from record profit to losses on price; no escape from the cycle, only dampening
- Third in overall DRAM share behind Samsung and SK Hynix — no verified HBM-specific share or Nvidia HBM4/Rubin allocation figure exists, so Micron's standing in the highest-value segment is unquantified
- Extreme, rising capital intensity (~$27B FY26 capex) that adds future supply/D&A and can seed the next glut
- High customer concentration in a few AI hyperscalers/GPU makers — de-qualification or a single platform loss is material
- SCA backlog covered only ~20% of DRAM and ~1/3 of NAND volume at floor prices at the Q3 FY26 call — most of the book still rides spot ASPs
- Peak margins leave no room for a normal cyclical disappointment — the ~11.3x trailing multiple at $855.10 (computed) rests on an 87.0% gross margin
Bottlenecks
- HBM/TSV advanced-packaging capacity — the binding constraint; Micron can fill only half-to-two-thirds of HBM demand (fact, Q3 FY26), so output, not orders, caps revenue
- Leading-edge wafer capacity (1-gamma DRAM/EUV) — limited and capex/time-gated; new fabs (Idaho/NY) take years to ramp
- EUV and advanced etch/deposition tool availability from ASML/AMAT/Lam — long lead times throttle how fast capacity can be added
- HBM yield (TSV stacking is yield-limiting) — improving yield is a constraint on effective HBM bit supply and margin
- Skilled fab labor and US construction timelines for greenfield fabs — execution risk on the onshoring buildout
- Power and water for fabs — large, growing utility footprint constrains siting and ramp speed
Top signals & trends
Top signals
3 sourced items since this entry's vintage are in the evidence rows (latest print, guidance, deals, resolved watch items); the analysis text is as of the entry's stated date and predates them unless dated otherwise.
The qualification milestone is cleared: Micron is in high-volume production of HBM4 (36GB 12-high) designed for NVIDIA Vera Rubin at >11 Gb/s pin speed and >2.8 TB/s bandwidth (~2.3x HBM3E) with >20% better power efficiency, and has shipped 16-high 48GB samples to customers (fact, Jul 2026); calendar-2026 HBM supply is fully sold out with pricing and volume locked, HBM4 included. What remains unresolved is allocation SHARE — the HBM-only split across Micron / SK Hynix / Samsung has no primary source, so treat any HBM-share figure as unverified. Verified OVERALL DRAM share (not HBM): Samsung ~39%, SK Hynix ~29%, Micron ~22%.
No verified evidence of ASP moderation as of the Nov 3 2026 close. Q3 FY26 DRAM ASPs rose low-60s % QoQ (fact, Q3 call), Q3 DRAM contracts were reported settling 20-30% HIGHER through the July selloff, CY2026 HBM pricing and volume are locked, and Q4 gross margin came in at 87.0% against a ~86% guide, with Q1 FY27 guided to ~86.25%, slightly below Q4 (fact). The cycle-top tell is unchanged — the inflection from decelerating-increase to outright decline — but nothing verified marks it yet. One early behavioural straw: reports that CoreWeave is exploring financial hedges against a decline in memory costs (Jul 2026, secondary source only — UNCONFIRMED).
The glut mechanism now has a named entity. CXMT (ChangXin Memory Technologies) IPO'd on the Shanghai A-share market on Jul 27 2026, raising RMB 57.92B (~$8.55-8.6B) at RMB 8.66/share — the largest semiconductor IPO in mainland China history — and closed up ~466% on debut (intraday as much as +531%). CXMT is on track to exit 2026 at ~350,000 wafer starts per month, within ~25,000 WSPM of Micron's own capacity, with global DRAM share ~7.6%, up from ~4.7% a quarter earlier (against Samsung ~39%, SK Hynix ~29%, Micron ~22%). The nuance that cuts the other way: >98% of CXMT revenue is COMMODITY DRAM with effectively no HBM presence, so the threat lands on Micron's conventional DRAM base, not the AI-memory franchise that carries the multiple. Micron's own FY27 step-up to ~$25B of net capex in the first half alone, with the second half higher (fact, 10-K), is supply the industry must also absorb. Still watch CY2027 supply-growth guidance against bit-demand growth.
The demand engine. Sustained or rising AI capex extends the tight cycle; any digestion/pause hits HBM first.
More take-or-pay coverage beyond ~20% of DRAM volume would further de-risk the cycle; watch for new SCAs and rising minimum-revenue figures.
Faster HBM4 yield/capacity ramp converts sold-out demand into revenue. Management targets HBM share near overall DRAM share.
Trends
Every Nvidia/AMD GPU needs multiple HBM stacks; HBM bit demand growing far faster than total DRAM. Core driver of the super-cycle.
Drove gross margin 57%→86% in three quarters. Positive now; reverses to negative if/when supply catches up.
Micron ~$27B + SK Hynix/Samsung adds + China entrants — the classic mechanism that ends every memory up-cycle.
SCAs convert commodity DRAM/NAND into contracted, margin-floored revenue — structurally new, dampens future volatility.
Funds US fabs and positions Micron as preferred secure-supply vendor; offset by export-control whiplash risk.
Subsidized capacity at the commodity low-end — a slow, structural commoditization threat over the long run.
Ecosystem & competitor graph
Suppliers feed the company; customers pull from it. Line thickness shows the strength of each tie (supply-chain dependency, customer earnings contribution). Hover to isolate a tie.
EUV/DUV lithography — gates leading-edge DRAM (1-gamma) and HBM capacity. Sole EUV supplier.
Deposition/etch/CMP and broad fab equipment for DRAM/NAND/HBM process steps.
Etch and deposition; named Micron customer relationship. Critical for 3D NAND and DRAM.
Process control, inspection, metrology — yield-critical for HBM TSV and leading-edge DRAM.
Japan-listed (8035.T). Coat/develop, etch, deposition equipment — major fab tool supplier.
Foundry for Micron's HBM4E custom base logic die from ~2027 — supplier of the logic layer.
The anchor HBM customer; HBM3E/HBM4 designed into GPUs (Blackwell/Rubin). Drives the AI-memory demand thesis.
HBM customer for Instinct AI accelerators; co-target of HBM4E custom base dies.
Custom AI ASIC / accelerator ecosystem (hyperscaler silicon) consuming HBM and high-cap DRAM.
Hyperscaler — data-center DRAM, high-cap DIMMs, and enterprise SSD demand; AI capex driver.
Hyperscaler + custom silicon (Trainium/Graviton) — server DRAM, HBM and data-center SSD buyer.
Server OEMs (also HPE, SMCI) — channel for data-center DRAM DIMMs and SSDs into enterprises.
Korea-listed (000660.KS). The HBM leader: ~50-62% HBM share and ~two-thirds of Nvidia HBM4/Rubin allocation. Micron's most important competitor — sets HBM pricing and pace.
Korea-listed (005930.KS). #1 in total DRAM, pushing hard on HBM4 to regain share; Micron has recently edged ahead of Samsung in HBM. Deepest balance sheet of the three.
Mainland-China DRAM entrant (named for analysis, not a recommendation). Subsidized capacity threatening the commodity-DRAM low-end over time.
Mainland-China NAND maker (named for analysis, not a recommendation). Long-run commoditization threat to NAND; constrained by US export controls on equipment.
Japan-listed (285A.T); JV with Western Digital's flash. NAND-only competitor; relevant to the ~24% of Micron revenue that is NAND, not the HBM growth engine.
US-listed NAND/flash pure-play (post WD-SanDisk split). Competes in NAND/SSD; no DRAM or HBM exposure.